Previous 10 | Next 10 |
GAITHERSBURG, Md., July 15, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, July 29, 2021 at 5:00 pm eastern time to discuss the financial results for the second quarter of 2021, recent business developments, revenue guidance for the ...
Tasos Katopodis/Getty Images News Emergent BioSolutions ([[EBS]] +1.1%) has gained in morning hours after the company announced that a government agency exercised an option to extend a contract term related to its supply of Smallpox vaccine into the U.S. Strategic National Stockpile...
They say that any publicity is good publicity. Emergent BioSolutions (NYSE: EBS) might disagree after its highly publicized COVID-19 vaccine manufacturing problems. In this Motley Fool Live video recorded on June 23 , Motley Fool contributors Keith Speights and Brian Or...
Scott Olson/Getty Images News The FDA has greenlighted another set of COVID-19 vaccine doses made for Johnson & Johnson ([[JNJ]] +1.7%) by the contract manufacturer Emergent BioSolutions ([[EBS]] +0.3%) at the company’s Baltimore manufacturing facility, Bloomberg reported. The...
New York, New York--(Newsfile Corp. - June 23, 2021) - Faruqi & Faruqi, LLP, a leading minority and Woman-owned national securities law firm, is investigating potential misconduct at Emergent BioSolutions Inc. ("Emergent BioSolutions" or the "Company") (NYSE: EBS). The investigation focus...
The law firm of Kessler Topaz Meltzer & Check, LLP announces that Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action against Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent”) on behalf investors who purchased or acquired Emergent common ...
SAN FRANCISCO, CA / ACCESSWIRE / June 16, 2021 / Hagens Berman urges Emergent BioSolutions Inc. (NYSE:EBS) investors with $100k or more losses to submit your losses now . Class Period: Apr. 24, 2020 - Apr. 16, 2021 Lead Plaintiff Deadline: June 18, 2021 Visit: www.hbsslaw.com/in...
Tasos Katopodis/Getty Images News The FDA has given the OK for Johnson & Johnson (JNJ) to distribute another 14M doses of its COVID-19 vaccine produced at an Emergent BioSolutions (EBS) Baltimore facility, Reuters reported. Nearly all of the doses that have been authorized to date are exp...
San Francisco, California--(Newsfile Corp. - June 15, 2021) - Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now . Class Period: Apr. 24, 2020 - Apr. 16, 2021 Lead Plaintiff Deadline: June 18, 2021 Visit: ...
Emergent continues to work with the FDA to address identified observations at Bayview facility in order to release additional batches and resume production GAITHERSBURG, Md., June 11, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that two batch...
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opio...
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of...
The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioid epidemic; product with the extended shelf life has officially begun shipping WINNIPEG, Manitoba, July 22, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolution...